Canadian biologists revealed that they have developed a new medical enzyme through genetically engineered corn that could be used to reduce the cost of treating a life-threatening inherited disease. Inserting a section of DNA code into maize seed caused them to make alpha-L-iduronidase in the endosperm, a nutritive tissue in the corn kernel. Alpha-L-iduronidase breaks down sugar molecules and is deficient in people with mucopolysaccheridosis I (MPS 1). ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment